1992 1993 outbreak strain Search Results


97
Pro-Lab Diagnostics 1992 1993 microbank system
Geographical origin, time of isolation, and maintenance of L. monocytogenes isolates
1992 1993 Microbank System, supplied by Pro-Lab Diagnostics, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/1992+1993+outbreak+strain/pmc00084179-115-91-94?v=Pro-Lab+Diagnostics
Average 97 stars, based on 1 article reviews
1992 1993 microbank system - by Bioz Stars, 2026-08
97/100 stars
  Buy from Supplier

90
Hartenstein GmbH neuroblasts (nbs)
Geographical origin, time of isolation, and maintenance of L. monocytogenes isolates
Neuroblasts (Nbs), supplied by Hartenstein GmbH, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/1992+1993+outbreak+strain/pm17404151-83-27-29?v=Hartenstein+GmbH
Average 90 stars, based on 1 article reviews
neuroblasts (nbs) - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier

90
Calmet Laboratory Services bupivacaine
Morphine compared with <t> bupivacaine </t> for pain control after knee arthroscopy
Bupivacaine, supplied by Calmet Laboratory Services, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/1992+1993+outbreak+strain/pmc06517216-1027-8-22?v=Calmet+Laboratory+Services
Average 90 stars, based on 1 article reviews
bupivacaine - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier

90
Joint Research Center advanced very high resolution radiometer (avhrr) data
Morphine compared with <t> bupivacaine </t> for pain control after knee arthroscopy
Advanced Very High Resolution Radiometer (Avhrr) Data, supplied by Joint Research Center, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/1992+1993+outbreak+strain/10__1080_slash_2150704x__2015__1101649-11-16-60?v=Joint+Research+Center
Average 90 stars, based on 1 article reviews
advanced very high resolution radiometer (avhrr) data - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier

97
ATCC ont par la suite confirmé la disparité entre ies deux virus
Morphine compared with <t> bupivacaine </t> for pain control after knee arthroscopy
Ont Par La Suite Confirmé La Disparité Entre Ies Deux Virus, supplied by ATCC, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/1992+1993+outbreak+strain/heppel_joel__1995__etudes_des_variations_genomiques_entre_differentes_souches_du_virus_de_la_necrose_pancreatique_infectieuse-1309-66-65?v=ATCC
Average 97 stars, based on 1 article reviews
ont par la suite confirmé la disparité entre ies deux virus - by Bioz Stars, 2026-08
97/100 stars
  Buy from Supplier

90
NORELL norell, 1992
Morphine compared with <t> bupivacaine </t> for pain control after knee arthroscopy
Norell, 1992, supplied by NORELL, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/1992+1993+outbreak+strain/10__1016_slash_j__earscirev__2010__04__001-672-46-47?v=NORELL
Average 90 stars, based on 1 article reviews
norell, 1992 - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier

90
Heiler Software AG sigmastat software
Morphine compared with <t> bupivacaine </t> for pain control after knee arthroscopy
Sigmastat Software, supplied by Heiler Software AG, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/1992+1993+outbreak+strain/pmc10143181-77-18-35?v=Heiler+Software+AG
Average 90 stars, based on 1 article reviews
sigmastat software - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier

90
Barents Group LLC urogenital surgery
Types of participants
Urogenital Surgery, supplied by Barents Group LLC, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/1992+1993+outbreak+strain/pmc08612698-1743-0-6?v=Barents+Group+LLC
Average 90 stars, based on 1 article reviews
urogenital surgery - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier

98
ATCC human penis carcinoma keratinocytes
Production of LPP in cells. (A) Scheme of the subdomain structure of the human zyxin, LPP, and TRIP6 proteins. All three proteins are composed of an N-terminal proline-rich domain (white box) and a C-terminal cysteine-rich portion composed of three LIM domains (gray boxes). LPP and zyxin contain FPPPP motifs in their N-terminal proline-rich domain (small boxes). (B) Specificity of anti-LPP antibodies. Total HeLa cell extracts were analyzed by SDS-PAGE and Western blotting with MP2, a serum directed against a synthetic LPP-derived peptide not present in zyxin or TRIP6 (amino acids 318–332; lane 1), with LPP2, an affinity-purified polyclonal antibody directed against a recombinant fusion protein containing amino acids 3–414 of LPP (GST-LPP3–414; lane 2), or with a monoclonal anti-zyxin antibody (lane 3). Note that zyxin migrates slower than LPP, confirming that LPP-specific antibodies do not recognize zyxin. The positions of molecular mass markers (kilodaltons) are shown on the left. (C) Expression of LPP in different human cells. Cell extracts were prepared from the following human cells and cell lines: foreskin fibroblasts (HFF), cervix carcinoma (HeLa), <t>keratinocytes</t> (Kera.), platelets (plat.), lymphocytes (HL60), and colon carcinoma (CaCo2). Approximately 15 μg of protein from each extract was analyzed by SDS-PAGE and Western blotting with MP2. The positions of molecular mass markers (kilodaltons) are shown on the left. (D) Quantitation of LPP and zyxin proteins in extracts from HFF, CaCo2, and LLC-PK1 cell lines. Values were obtained by quantifying LPP- or zyxin-specific protein bands with the use of a Cy5-based detection method (see MATERIALS AND METHODS). aThese values have been published elsewhere (Fradelizi et al., 1999 ) but are shown here for comparison.
Human Penis Carcinoma Keratinocytes, supplied by ATCC, used in various techniques. Bioz Stars score: 98/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/1992+1993+outbreak+strain/pmc00014761-61-45-43?v=ATCC
Average 98 stars, based on 1 article reviews
human penis carcinoma keratinocytes - by Bioz Stars, 2026-08
98/100 stars
  Buy from Supplier

90
Johns Hopkins HealthCare antibodies to gm1 and gd1a gangliosides
Production of LPP in cells. (A) Scheme of the subdomain structure of the human zyxin, LPP, and TRIP6 proteins. All three proteins are composed of an N-terminal proline-rich domain (white box) and a C-terminal cysteine-rich portion composed of three LIM domains (gray boxes). LPP and zyxin contain FPPPP motifs in their N-terminal proline-rich domain (small boxes). (B) Specificity of anti-LPP antibodies. Total HeLa cell extracts were analyzed by SDS-PAGE and Western blotting with MP2, a serum directed against a synthetic LPP-derived peptide not present in zyxin or TRIP6 (amino acids 318–332; lane 1), with LPP2, an affinity-purified polyclonal antibody directed against a recombinant fusion protein containing amino acids 3–414 of LPP (GST-LPP3–414; lane 2), or with a monoclonal anti-zyxin antibody (lane 3). Note that zyxin migrates slower than LPP, confirming that LPP-specific antibodies do not recognize zyxin. The positions of molecular mass markers (kilodaltons) are shown on the left. (C) Expression of LPP in different human cells. Cell extracts were prepared from the following human cells and cell lines: foreskin fibroblasts (HFF), cervix carcinoma (HeLa), <t>keratinocytes</t> (Kera.), platelets (plat.), lymphocytes (HL60), and colon carcinoma (CaCo2). Approximately 15 μg of protein from each extract was analyzed by SDS-PAGE and Western blotting with MP2. The positions of molecular mass markers (kilodaltons) are shown on the left. (D) Quantitation of LPP and zyxin proteins in extracts from HFF, CaCo2, and LLC-PK1 cell lines. Values were obtained by quantifying LPP- or zyxin-specific protein bands with the use of a Cy5-based detection method (see MATERIALS AND METHODS). aThese values have been published elsewhere (Fradelizi et al., 1999 ) but are shown here for comparison.
Antibodies To Gm1 And Gd1a Gangliosides, supplied by Johns Hopkins HealthCare, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/1992+1993+outbreak+strain/pm21504498-38-36-4?v=Johns+Hopkins+HealthCare
Average 90 stars, based on 1 article reviews
antibodies to gm1 and gd1a gangliosides - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier

90
Kemper GmbH letter reminder or recall interventions
Production of LPP in cells. (A) Scheme of the subdomain structure of the human zyxin, LPP, and TRIP6 proteins. All three proteins are composed of an N-terminal proline-rich domain (white box) and a C-terminal cysteine-rich portion composed of three LIM domains (gray boxes). LPP and zyxin contain FPPPP motifs in their N-terminal proline-rich domain (small boxes). (B) Specificity of anti-LPP antibodies. Total HeLa cell extracts were analyzed by SDS-PAGE and Western blotting with MP2, a serum directed against a synthetic LPP-derived peptide not present in zyxin or TRIP6 (amino acids 318–332; lane 1), with LPP2, an affinity-purified polyclonal antibody directed against a recombinant fusion protein containing amino acids 3–414 of LPP (GST-LPP3–414; lane 2), or with a monoclonal anti-zyxin antibody (lane 3). Note that zyxin migrates slower than LPP, confirming that LPP-specific antibodies do not recognize zyxin. The positions of molecular mass markers (kilodaltons) are shown on the left. (C) Expression of LPP in different human cells. Cell extracts were prepared from the following human cells and cell lines: foreskin fibroblasts (HFF), cervix carcinoma (HeLa), <t>keratinocytes</t> (Kera.), platelets (plat.), lymphocytes (HL60), and colon carcinoma (CaCo2). Approximately 15 μg of protein from each extract was analyzed by SDS-PAGE and Western blotting with MP2. The positions of molecular mass markers (kilodaltons) are shown on the left. (D) Quantitation of LPP and zyxin proteins in extracts from HFF, CaCo2, and LLC-PK1 cell lines. Values were obtained by quantifying LPP- or zyxin-specific protein bands with the use of a Cy5-based detection method (see MATERIALS AND METHODS). aThese values have been published elsewhere (Fradelizi et al., 1999 ) but are shown here for comparison.
Letter Reminder Or Recall Interventions, supplied by Kemper GmbH, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/1992+1993+outbreak+strain/10__1002_slash_14651858__cd003941__pub3-320-7-20?v=Kemper+GmbH
Average 90 stars, based on 1 article reviews
letter reminder or recall interventions - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier

99
Akoya Biosciences 280 regulatory standards
Production of LPP in cells. (A) Scheme of the subdomain structure of the human zyxin, LPP, and TRIP6 proteins. All three proteins are composed of an N-terminal proline-rich domain (white box) and a C-terminal cysteine-rich portion composed of three LIM domains (gray boxes). LPP and zyxin contain FPPPP motifs in their N-terminal proline-rich domain (small boxes). (B) Specificity of anti-LPP antibodies. Total HeLa cell extracts were analyzed by SDS-PAGE and Western blotting with MP2, a serum directed against a synthetic LPP-derived peptide not present in zyxin or TRIP6 (amino acids 318–332; lane 1), with LPP2, an affinity-purified polyclonal antibody directed against a recombinant fusion protein containing amino acids 3–414 of LPP (GST-LPP3–414; lane 2), or with a monoclonal anti-zyxin antibody (lane 3). Note that zyxin migrates slower than LPP, confirming that LPP-specific antibodies do not recognize zyxin. The positions of molecular mass markers (kilodaltons) are shown on the left. (C) Expression of LPP in different human cells. Cell extracts were prepared from the following human cells and cell lines: foreskin fibroblasts (HFF), cervix carcinoma (HeLa), <t>keratinocytes</t> (Kera.), platelets (plat.), lymphocytes (HL60), and colon carcinoma (CaCo2). Approximately 15 μg of protein from each extract was analyzed by SDS-PAGE and Western blotting with MP2. The positions of molecular mass markers (kilodaltons) are shown on the left. (D) Quantitation of LPP and zyxin proteins in extracts from HFF, CaCo2, and LLC-PK1 cell lines. Values were obtained by quantifying LPP- or zyxin-specific protein bands with the use of a Cy5-based detection method (see MATERIALS AND METHODS). aThese values have been published elsewhere (Fradelizi et al., 1999 ) but are shown here for comparison.
280 Regulatory Standards, supplied by Akoya Biosciences, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/1992+1993+outbreak+strain/pm30562601-173-19-22?v=Akoya+Biosciences
Average 99 stars, based on 1 article reviews
280 regulatory standards - by Bioz Stars, 2026-08
99/100 stars
  Buy from Supplier

Image Search Results


Geographical origin, time of isolation, and maintenance of L. monocytogenes isolates

Journal:

Article Title: Typing of Listeria monocytogenes Strains by Repetitive Element Sequence-Based PCR

doi:

Figure Lengend Snippet: Geographical origin, time of isolation, and maintenance of L. monocytogenes isolates

Article Snippet: Characteristics of L. monocytogenes strains isolated from humans, animals, and foods and REP and ERIC types table ft1 table-wrap mode="anchored" t5 TABLE 2 caption a7 Geographical region of origin of isolate a Isolate designation Date of isolation Maintenance of isolates before the present research was begun Ljubljana 1–27 1980–1985 Bacterial strain storage medium (Sanofi Diagnostics, Pasteur, Marnes-la-Coquette, France) at 4°C without subculturing Smoljan (Rodopi mountain) 28 1972 Lyophilized 30 1983 31, 32 1984 Sofia (Kostenez) 29 1972 Lyophilized Ljubljana 33 1985 Nutrient agar at 4°C subcultured every 4 mo Ljubljana 34–58 1992–1993 Microbank system (Pro-Lab Diagnostics, Richmond Hill, Ontario, Canada) subcultured every 6 mo Ptuj 59–64 1993 Nutrient agar at 4°C subcultured every 4 mo Open in a separate window a The regions of Ljublana and Ptuj are in central and northeastern Slovenia, respectively.

Techniques: Isolation, Subculturing Assay, Surround Optical-fiber Immunoassay

Morphine compared with  bupivacaine  for pain control after knee arthroscopy

Journal: The Cochrane Database of Systematic Reviews

Article Title: Single dose intra‐articular morphine for pain control after knee arthroscopy

doi: 10.1002/14651858.CD008918.pub2

Figure Lengend Snippet: Morphine compared with bupivacaine for pain control after knee arthroscopy

Article Snippet: The active drugs relevant to our studies included bupivacaine ( Aasbø 1996 ; Alagol 2005 ; Allen 1993 ; Bjornsson 1994 ; Calmet 2004 ; De Andres 1998 ; Follak 2001 ; Khoury 1992 ; Richardson 1997 ; Ruwe 1995 ), ropivacaine ( Franceschi 2001 ; Muller 2001 ), tenoxicam ( Alagol 2005 ; Guler 2002 ), tramadol ( Akinci 2003 ; Likar 1995 ), sufentanil ( Kazemi 2004 ), fentanyl ( Varkel 1999 ), pethidine ( Lyons 1995 ), morphine injected IV/IM ( Christensen 1996 ; Dierking 1994 ; Raj 2004 ; Richardson 1997 ; Rosseland 2003a ) and different doses of morphine ( Allen 1993 ; Kanbak 1997 ; Kizilkaya 2005 ; Likar 1999 ).

Techniques: Control, Comparison

Forest plot of comparison: 1 pain intensity VAS score, outcome: 1.2 1mg morphine vs bupivacaine.

Journal: The Cochrane Database of Systematic Reviews

Article Title: Single dose intra‐articular morphine for pain control after knee arthroscopy

doi: 10.1002/14651858.CD008918.pub2

Figure Lengend Snippet: Forest plot of comparison: 1 pain intensity VAS score, outcome: 1.2 1mg morphine vs bupivacaine.

Article Snippet: The active drugs relevant to our studies included bupivacaine ( Aasbø 1996 ; Alagol 2005 ; Allen 1993 ; Bjornsson 1994 ; Calmet 2004 ; De Andres 1998 ; Follak 2001 ; Khoury 1992 ; Richardson 1997 ; Ruwe 1995 ), ropivacaine ( Franceschi 2001 ; Muller 2001 ), tenoxicam ( Alagol 2005 ; Guler 2002 ), tramadol ( Akinci 2003 ; Likar 1995 ), sufentanil ( Kazemi 2004 ), fentanyl ( Varkel 1999 ), pethidine ( Lyons 1995 ), morphine injected IV/IM ( Christensen 1996 ; Dierking 1994 ; Raj 2004 ; Richardson 1997 ; Rosseland 2003a ) and different doses of morphine ( Allen 1993 ; Kanbak 1997 ; Kizilkaya 2005 ; Likar 1999 ).

Techniques: Comparison

Comparison 1 Pain intensity VAS score, Outcome 2 1mg morphine vs bupivacaine.

Journal: The Cochrane Database of Systematic Reviews

Article Title: Single dose intra‐articular morphine for pain control after knee arthroscopy

doi: 10.1002/14651858.CD008918.pub2

Figure Lengend Snippet: Comparison 1 Pain intensity VAS score, Outcome 2 1mg morphine vs bupivacaine.

Article Snippet: The active drugs relevant to our studies included bupivacaine ( Aasbø 1996 ; Alagol 2005 ; Allen 1993 ; Bjornsson 1994 ; Calmet 2004 ; De Andres 1998 ; Follak 2001 ; Khoury 1992 ; Richardson 1997 ; Ruwe 1995 ), ropivacaine ( Franceschi 2001 ; Muller 2001 ), tenoxicam ( Alagol 2005 ; Guler 2002 ), tramadol ( Akinci 2003 ; Likar 1995 ), sufentanil ( Kazemi 2004 ), fentanyl ( Varkel 1999 ), pethidine ( Lyons 1995 ), morphine injected IV/IM ( Christensen 1996 ; Dierking 1994 ; Raj 2004 ; Richardson 1997 ; Rosseland 2003a ) and different doses of morphine ( Allen 1993 ; Kanbak 1997 ; Kizilkaya 2005 ; Likar 1999 ).

Techniques: Comparison

Comparison 3 Adverse events, Outcome 2 morphine vs bupivacaine.

Journal: The Cochrane Database of Systematic Reviews

Article Title: Single dose intra‐articular morphine for pain control after knee arthroscopy

doi: 10.1002/14651858.CD008918.pub2

Figure Lengend Snippet: Comparison 3 Adverse events, Outcome 2 morphine vs bupivacaine.

Article Snippet: The active drugs relevant to our studies included bupivacaine ( Aasbø 1996 ; Alagol 2005 ; Allen 1993 ; Bjornsson 1994 ; Calmet 2004 ; De Andres 1998 ; Follak 2001 ; Khoury 1992 ; Richardson 1997 ; Ruwe 1995 ), ropivacaine ( Franceschi 2001 ; Muller 2001 ), tenoxicam ( Alagol 2005 ; Guler 2002 ), tramadol ( Akinci 2003 ; Likar 1995 ), sufentanil ( Kazemi 2004 ), fentanyl ( Varkel 1999 ), pethidine ( Lyons 1995 ), morphine injected IV/IM ( Christensen 1996 ; Dierking 1994 ; Raj 2004 ; Richardson 1997 ; Rosseland 2003a ) and different doses of morphine ( Allen 1993 ; Kanbak 1997 ; Kizilkaya 2005 ; Likar 1999 ).

Techniques: Comparison

Pain intensity VAS score

Journal: The Cochrane Database of Systematic Reviews

Article Title: Single dose intra‐articular morphine for pain control after knee arthroscopy

doi: 10.1002/14651858.CD008918.pub2

Figure Lengend Snippet: Pain intensity VAS score

Article Snippet: The active drugs relevant to our studies included bupivacaine ( Aasbø 1996 ; Alagol 2005 ; Allen 1993 ; Bjornsson 1994 ; Calmet 2004 ; De Andres 1998 ; Follak 2001 ; Khoury 1992 ; Richardson 1997 ; Ruwe 1995 ), ropivacaine ( Franceschi 2001 ; Muller 2001 ), tenoxicam ( Alagol 2005 ; Guler 2002 ), tramadol ( Akinci 2003 ; Likar 1995 ), sufentanil ( Kazemi 2004 ), fentanyl ( Varkel 1999 ), pethidine ( Lyons 1995 ), morphine injected IV/IM ( Christensen 1996 ; Dierking 1994 ; Raj 2004 ; Richardson 1997 ; Rosseland 2003a ) and different doses of morphine ( Allen 1993 ; Kanbak 1997 ; Kizilkaya 2005 ; Likar 1999 ).

Techniques: Comparison

Analgesia duration

Journal: The Cochrane Database of Systematic Reviews

Article Title: Single dose intra‐articular morphine for pain control after knee arthroscopy

doi: 10.1002/14651858.CD008918.pub2

Figure Lengend Snippet: Analgesia duration

Article Snippet: The active drugs relevant to our studies included bupivacaine ( Aasbø 1996 ; Alagol 2005 ; Allen 1993 ; Bjornsson 1994 ; Calmet 2004 ; De Andres 1998 ; Follak 2001 ; Khoury 1992 ; Richardson 1997 ; Ruwe 1995 ), ropivacaine ( Franceschi 2001 ; Muller 2001 ), tenoxicam ( Alagol 2005 ; Guler 2002 ), tramadol ( Akinci 2003 ; Likar 1995 ), sufentanil ( Kazemi 2004 ), fentanyl ( Varkel 1999 ), pethidine ( Lyons 1995 ), morphine injected IV/IM ( Christensen 1996 ; Dierking 1994 ; Raj 2004 ; Richardson 1997 ; Rosseland 2003a ) and different doses of morphine ( Allen 1993 ; Kanbak 1997 ; Kizilkaya 2005 ; Likar 1999 ).

Techniques: Comparison

Adverse events

Journal: The Cochrane Database of Systematic Reviews

Article Title: Single dose intra‐articular morphine for pain control after knee arthroscopy

doi: 10.1002/14651858.CD008918.pub2

Figure Lengend Snippet: Adverse events

Article Snippet: The active drugs relevant to our studies included bupivacaine ( Aasbø 1996 ; Alagol 2005 ; Allen 1993 ; Bjornsson 1994 ; Calmet 2004 ; De Andres 1998 ; Follak 2001 ; Khoury 1992 ; Richardson 1997 ; Ruwe 1995 ), ropivacaine ( Franceschi 2001 ; Muller 2001 ), tenoxicam ( Alagol 2005 ; Guler 2002 ), tramadol ( Akinci 2003 ; Likar 1995 ), sufentanil ( Kazemi 2004 ), fentanyl ( Varkel 1999 ), pethidine ( Lyons 1995 ), morphine injected IV/IM ( Christensen 1996 ; Dierking 1994 ; Raj 2004 ; Richardson 1997 ; Rosseland 2003a ) and different doses of morphine ( Allen 1993 ; Kanbak 1997 ; Kizilkaya 2005 ; Likar 1999 ).

Techniques: Comparison

Types of participants

Journal: The Cochrane Database of Systematic Reviews

Article Title: Urethral (indwelling or intermittent) or suprapubic routes for short‐term catheterisation in hospitalised adults

doi: 10.1002/14651858.CD004203.pub3

Figure Lengend Snippet: Types of participants

Article Snippet: Urogenital surgery (Ahmed 1993; Andersen 1985; Barents 1978; Bergman 1987; Dixon 2010; Hakvoort 2011; Hammarsten 1992; Harms 1985; Jannelli 2007; Korkes 2008; Kringel 2010; Prasad 2014; Schiotz 1989; Stekkinger 2011; Wiser 1974).

Techniques: Dissection

Indwelling urethral catheterisation compared to intermittent urethral catheterisation for short‐term catheterisation in adults

Journal: The Cochrane Database of Systematic Reviews

Article Title: Urethral (indwelling or intermittent) or suprapubic routes for short‐term catheterisation in hospitalised adults

doi: 10.1002/14651858.CD004203.pub3

Figure Lengend Snippet: Indwelling urethral catheterisation compared to intermittent urethral catheterisation for short‐term catheterisation in adults

Article Snippet: Urogenital surgery (Ahmed 1993; Andersen 1985; Barents 1978; Bergman 1987; Dixon 2010; Hakvoort 2011; Hammarsten 1992; Harms 1985; Jannelli 2007; Korkes 2008; Kringel 2010; Prasad 2014; Schiotz 1989; Stekkinger 2011; Wiser 1974).

Techniques: Comparison, Control

Indwelling urethral vs suprapubic catheterisation

Journal: The Cochrane Database of Systematic Reviews

Article Title: Urethral (indwelling or intermittent) or suprapubic routes for short‐term catheterisation in hospitalised adults

doi: 10.1002/14651858.CD004203.pub3

Figure Lengend Snippet: Indwelling urethral vs suprapubic catheterisation

Article Snippet: Urogenital surgery (Ahmed 1993; Andersen 1985; Barents 1978; Bergman 1987; Dixon 2010; Hakvoort 2011; Hammarsten 1992; Harms 1985; Jannelli 2007; Korkes 2008; Kringel 2010; Prasad 2014; Schiotz 1989; Stekkinger 2011; Wiser 1974).

Techniques:

Urethral vs intermittent catheterisation

Journal: The Cochrane Database of Systematic Reviews

Article Title: Urethral (indwelling or intermittent) or suprapubic routes for short‐term catheterisation in hospitalised adults

doi: 10.1002/14651858.CD004203.pub3

Figure Lengend Snippet: Urethral vs intermittent catheterisation

Article Snippet: Urogenital surgery (Ahmed 1993; Andersen 1985; Barents 1978; Bergman 1987; Dixon 2010; Hakvoort 2011; Hammarsten 1992; Harms 1985; Jannelli 2007; Korkes 2008; Kringel 2010; Prasad 2014; Schiotz 1989; Stekkinger 2011; Wiser 1974).

Techniques:

Production of LPP in cells. (A) Scheme of the subdomain structure of the human zyxin, LPP, and TRIP6 proteins. All three proteins are composed of an N-terminal proline-rich domain (white box) and a C-terminal cysteine-rich portion composed of three LIM domains (gray boxes). LPP and zyxin contain FPPPP motifs in their N-terminal proline-rich domain (small boxes). (B) Specificity of anti-LPP antibodies. Total HeLa cell extracts were analyzed by SDS-PAGE and Western blotting with MP2, a serum directed against a synthetic LPP-derived peptide not present in zyxin or TRIP6 (amino acids 318–332; lane 1), with LPP2, an affinity-purified polyclonal antibody directed against a recombinant fusion protein containing amino acids 3–414 of LPP (GST-LPP3–414; lane 2), or with a monoclonal anti-zyxin antibody (lane 3). Note that zyxin migrates slower than LPP, confirming that LPP-specific antibodies do not recognize zyxin. The positions of molecular mass markers (kilodaltons) are shown on the left. (C) Expression of LPP in different human cells. Cell extracts were prepared from the following human cells and cell lines: foreskin fibroblasts (HFF), cervix carcinoma (HeLa), keratinocytes (Kera.), platelets (plat.), lymphocytes (HL60), and colon carcinoma (CaCo2). Approximately 15 μg of protein from each extract was analyzed by SDS-PAGE and Western blotting with MP2. The positions of molecular mass markers (kilodaltons) are shown on the left. (D) Quantitation of LPP and zyxin proteins in extracts from HFF, CaCo2, and LLC-PK1 cell lines. Values were obtained by quantifying LPP- or zyxin-specific protein bands with the use of a Cy5-based detection method (see MATERIALS AND METHODS). aThese values have been published elsewhere (Fradelizi et al., 1999 ) but are shown here for comparison.

Journal:

Article Title: LPP, an Actin Cytoskeleton Protein Related to Zyxin, Harbors a Nuclear Export Signal and Transcriptional Activation Capacity

doi:

Figure Lengend Snippet: Production of LPP in cells. (A) Scheme of the subdomain structure of the human zyxin, LPP, and TRIP6 proteins. All three proteins are composed of an N-terminal proline-rich domain (white box) and a C-terminal cysteine-rich portion composed of three LIM domains (gray boxes). LPP and zyxin contain FPPPP motifs in their N-terminal proline-rich domain (small boxes). (B) Specificity of anti-LPP antibodies. Total HeLa cell extracts were analyzed by SDS-PAGE and Western blotting with MP2, a serum directed against a synthetic LPP-derived peptide not present in zyxin or TRIP6 (amino acids 318–332; lane 1), with LPP2, an affinity-purified polyclonal antibody directed against a recombinant fusion protein containing amino acids 3–414 of LPP (GST-LPP3–414; lane 2), or with a monoclonal anti-zyxin antibody (lane 3). Note that zyxin migrates slower than LPP, confirming that LPP-specific antibodies do not recognize zyxin. The positions of molecular mass markers (kilodaltons) are shown on the left. (C) Expression of LPP in different human cells. Cell extracts were prepared from the following human cells and cell lines: foreskin fibroblasts (HFF), cervix carcinoma (HeLa), keratinocytes (Kera.), platelets (plat.), lymphocytes (HL60), and colon carcinoma (CaCo2). Approximately 15 μg of protein from each extract was analyzed by SDS-PAGE and Western blotting with MP2. The positions of molecular mass markers (kilodaltons) are shown on the left. (D) Quantitation of LPP and zyxin proteins in extracts from HFF, CaCo2, and LLC-PK1 cell lines. Values were obtained by quantifying LPP- or zyxin-specific protein bands with the use of a Cy5-based detection method (see MATERIALS AND METHODS). aThese values have been published elsewhere (Fradelizi et al., 1999 ) but are shown here for comparison.

Article Snippet: Cell Lines and Cells The human cervix carcinoma HeLa cell line (American Type Culture Collection [ATCC; Rockville, MD] CCL-2), African green monkey kidney Vero cell line (ATCC CCL-81), porcine proximal kidney epithelial LLC-PK1 cell line (ATCC CL-101), human colon adenocarcinoma CaCo2 cell line (ATCC HTB-37), human penis carcinoma keratinocytes ( Rogel-Gaillard et al. , 1992 ; Robine et al. , 1993 ), and human foreskin fibroblasts (HFF) (Dr. A. Rochat, Ecole Normale Superieure, Paris, France) were grown in DMEM supplemented with 10% FCS (complete medium).

Techniques: SDS Page, Western Blot, Derivative Assay, Affinity Purification, Recombinant, Expressing, Quantitation Assay, Comparison

Intracellular distribution of LPP in cultured cells. Cells were fixed, detergent permeabilized, and doubly stained by indirect immunofluorescence. (A–D) HFF cells doubly stained with affinity-purified LPP2 antibody (A and C) and with either monoclonal anti-vinculin (B) or anti-zyxin (D) antibody. Views were obtained by epifluorescence microscopy. The insets show 2.2-fold magnified details of images C and D. Ventral faces of the cells are shown. (E and F) Keratinocytes doubly stained with affinity-purified LPP2 antibody (E) and with monoclonal anti-vinculin antibody (F). Views were obtained by confocal laser scanning microscopy. Three apical sections were compiled. LPP codistributes with vinculin, which was used as a marker for focal adhesions (B) and cell-to-cell contacts (F). Note that in contrast to LPP, zyxin staining is not restricted to focal adhesions but is also found along actin stress fibers (D). LPP2 staining is also visible in the nucleus. Bars, 20 μm.

Journal:

Article Title: LPP, an Actin Cytoskeleton Protein Related to Zyxin, Harbors a Nuclear Export Signal and Transcriptional Activation Capacity

doi:

Figure Lengend Snippet: Intracellular distribution of LPP in cultured cells. Cells were fixed, detergent permeabilized, and doubly stained by indirect immunofluorescence. (A–D) HFF cells doubly stained with affinity-purified LPP2 antibody (A and C) and with either monoclonal anti-vinculin (B) or anti-zyxin (D) antibody. Views were obtained by epifluorescence microscopy. The insets show 2.2-fold magnified details of images C and D. Ventral faces of the cells are shown. (E and F) Keratinocytes doubly stained with affinity-purified LPP2 antibody (E) and with monoclonal anti-vinculin antibody (F). Views were obtained by confocal laser scanning microscopy. Three apical sections were compiled. LPP codistributes with vinculin, which was used as a marker for focal adhesions (B) and cell-to-cell contacts (F). Note that in contrast to LPP, zyxin staining is not restricted to focal adhesions but is also found along actin stress fibers (D). LPP2 staining is also visible in the nucleus. Bars, 20 μm.

Article Snippet: Cell Lines and Cells The human cervix carcinoma HeLa cell line (American Type Culture Collection [ATCC; Rockville, MD] CCL-2), African green monkey kidney Vero cell line (ATCC CCL-81), porcine proximal kidney epithelial LLC-PK1 cell line (ATCC CL-101), human colon adenocarcinoma CaCo2 cell line (ATCC HTB-37), human penis carcinoma keratinocytes ( Rogel-Gaillard et al. , 1992 ; Robine et al. , 1993 ), and human foreskin fibroblasts (HFF) (Dr. A. Rochat, Ecole Normale Superieure, Paris, France) were grown in DMEM supplemented with 10% FCS (complete medium).

Techniques: Cell Culture, Staining, Immunofluorescence, Affinity Purification, Epifluorescence Microscopy, Confocal Laser Scanning Microscopy, Marker